Persistent URL of this record https://hdl.handle.net/1887/121141
In Collections
This item can be found in the following collections:
![Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
- All authors
- Meijer, T.S.; Burgmans, M.C.; Fiocco, M.; Geus-Oei, L.F. de; Kapiteijn, E.; Leede, E.M. de; Martini, C.H.; Meer, R.W. van der; Tijl, F.G.J.; Vahrmeijer, A.L.
- Date
- 2019-06-30
- Volume
- 42
- Issue
- 6
- Pages
- 841 - 852